Literature DB >> 25584230

Primary MPNST in Childhood- A Rare Case Report.

Sandip Kudesia1, Aparna Bhardwaj2, Brijesh Thakur3, Sanjeev Kishore4, Neelima Bahal5.   

Abstract

Malignant peripheral nerve sheath tumour usually occurs between 20-50 years of age, comprising about 5-10% of soft tissue sarcomas. Only 1.7% of them have been reported to occur in children < 5 months of age according to the literature. Here, we are describing 18 mnth old male child presented with a swelling in the lower back. MRI showed a sacrcoccygeal swelling extending to and communicating with CSF at lower sacral level. Birth history of the child was normal with normal apgar score. The histological diagnosis was malignant peripheral nerve sheath tumour. IHC showed focal positivity of GFAP and S100. Primary spinal MPNST in children are rarer. A careful neurological examination is warranted in children. Early diagnosis and referral to multidisciplinary team are important in ensuring the best diagnosis and optimal therapy in this young age.

Entities:  

Keywords:  Child; Lipomeningocele; Neural; Neurofibromatosis; Sacral

Year:  2014        PMID: 25584230      PMCID: PMC4290249          DOI: 10.7860/JCDR/2014/9380.5111

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  Malignant peripheral nerve sheath tumors: clinicopathological profile of 63 cases diagnosed at a tertiary cancer referral center in Mumbai, India.

Authors:  Bharat Rekhi; Abhijeet Ingle; Rajiv Kumar; Maria Alina DeSouza; Rajesh Dikshit; Nirmala A Jambhekar
Journal:  Indian J Pathol Microbiol       Date:  2010 Oct-Dec       Impact factor: 0.740

Review 2.  Malignant peripheral nerve sheath tumor of the lumbar spine.

Authors:  Brent K Ogawa; David L Skaggs; Robert M Kay
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2009-05

3.  Primary spinal malignant schwannomas: clinical and prognostic remarks.

Authors:  P Celli; L Cervoni; R Tarantino; A Fortuna
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases.

Authors:  B S Ducatman; B W Scheithauer; D G Piepgras; H M Reiman; D M Ilstrup
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

5.  Cellular schwannoma. A clinicopathologic study of 57 patients and 58 tumors.

Authors:  W White; M H Shiu; M K Rosenblum; R A Erlandson; J M Woodruff
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

Review 6.  Soft tissue sarcomas.

Authors:  J J Lewis; M F Brennan
Journal:  Curr Probl Surg       Date:  1996-10       Impact factor: 1.909

7.  Malignant peripheral nerve sheath tumor of the cauda equina.

Authors:  R Acharya; S Bhalla; A D Sehgal
Journal:  Neurol Sci       Date:  2001-06       Impact factor: 3.307

8.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

9.  Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors.

Authors:  H P Kourea; M H Bilsky; D H Leung; J J Lewis; J M Woodruff
Journal:  Cancer       Date:  1998-06-01       Impact factor: 6.860

10.  Spinal malignant nerve-sheath tumor or cellular schwannoma? A striking difference in prognosis.

Authors:  M T Seppälä; M J Haltia
Journal:  J Neurosurg       Date:  1993-10       Impact factor: 5.115

  10 in total
  2 in total

1.  Predictive Modeling for Clinical Features Associated With Neurofibromatosis Type 1.

Authors:  Stephanie M Morris; Aditi Gupta; Seunghwan Kim; Randi E Foraker; David H Gutmann; Philip R O Payne
Journal:  Neurol Clin Pract       Date:  2021-12

Review 2.  Responsible, practical genomic data sharing that accelerates research.

Authors:  James Brian Byrd; Anna C Greene; Deepashree Venkatesh Prasad; Xiaoqian Jiang; Casey S Greene
Journal:  Nat Rev Genet       Date:  2020-07-21       Impact factor: 53.242

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.